Analysis of the mRNA expression of the TGF-beta family in testicular cells and localization of the splice variant TGF-β2B in testis

Molecular Reproduction and Development

Volumn 73, Issue 10, 2006, Pages 1211-1220

  Konrad, Lutz ^a   Lüers, Georg H ^a   Völck Babouin, Elke ^a   Keilani, Marcel M ^a   Laible, Leslie ^a   Aumüller, Gerhard ^a   Hofmann, Rainer ^a  

^a Medical Faculty   (Germany)

Author keywords

Alternative splicing; T R; Testis; TGF

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD TESTIS BARRIER; CONTROLLED STUDY; DNA SYNTHESIS; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; HUMAN; LEYDIG CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPERMATOGONIUM; TESTIS; TESTIS CELL;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; EXONS; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TESTIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

EID: 33748300911     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20399     Document Type: Article

References (50)

1. Agrotis A, Samuel M, Prapas G, Bobik A. 1996. Vascular smooth muscle cells express multiple type I receptors for TGF-β, activin, and bone morphogenetic proteins. Biochem Biophys Res Commun 219:613-618.
2. Agrotis A, Condron M, Bobik A. 2000. Alternative splicing within the TGF-β I receptor gene (ALK-5) generates two major functional isoforms in vascular smooth muscle cells. FEBS Lett 467:128-132.
3. Albrecht M, Renneberg H, Wennemuth G, Moschler O, Janssen M, Aumuller G, Konrad L. 1999. Fibronectin in human prostatic cells in vivo and in vitro: Expression, distribution, and pathological significance. Histochem Cell Biol 112:51-61.
4. Annes JP, Hunger JS, Rifkin DB. 2003. Making sense of latent TGFβ activation. J Cell Sci 116:217-224.
5. Bhowmick MA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. 2004. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848-851.
6. Chang H, Brown CW, Matzuk MM. 2002. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 23:787-823.
7. de Caestecker M. 2004. The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev 15:1-11.
8. Del Re E, Babitt JL, Pirani A, Schneyer AL, Lin HY. 2004. In the absence of type III receptor, the TGF-β type II-B receptor requires the type I receptor to bind TGF-β2. J Biol Chem 279:22765-22772.
9. Gautier C, Levacher C, Avallet O, Vigier M, Rouiller-Fabre V, Lecerf L, Saez J, Habert R. 1994. Immunohistochemical localization of transforming growth factor-β1 in the fetal and neonatal rat testis. Mol Cell Endocrinol 99:55-61.
10. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, Danias J, Bronstein JM, Kachar B, Lazzarini RA. 1999. CNS myelin and Sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 99:649-659.
11. Haagmans BL, Hoogerbrugge JW, Themmen AP, Teerds KJ. 2003. Rat testicular germ cells and Sertoli cells release different types of bioactive transforming growth factor beta in vitro. Reprod Biol Endocrinol 1:3.
12. Hirai R, Fujita T. 1996. A human transforming growth factor-β type II receptor that contains an insertion in the extracellular domain. Exp Cell Res 223:135-141.
13. Hoeben E, Briers T, Vanderstichele H, De Smet W, Heyns W, Deboel L, Vanderhoydonck F, Verhoeven G. 1995. Characterization of newly established testicular peritubular and prostatic stromal cell lines: Potential use in the study of mesenchymal-epithelial interactions. Endocrinology 136:2862-2873.
14. Hofmann MC, Narisawa S, Hess RA, Millan JL. 1992. Immortalization of germ cells and somatic testicular cells using the SV40 large T antigen. Exp Cell Res 201:417-435.
15. Ikeda T, Lioubin MN, Marquardt H. 1987. Human transforming growth factor type β2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry 26:2406-2410.
16. Jiang C, Hall SJ, Boekelheide K. 1997. Development and characterization of a prepubertal rat Sertoli cell line, 93RS2. J Androl 18:393-399.
17. Kochiwa H, Suzuki R, Washio T, Saito R, Bono H, Carninci P, Okazaki Y, Miki R, Hayashizaki Y, Tomita M, RIKEN Genome Exploration Research Group Phase II Team. 2002. Inferring alternative splicing patterns in mouse from a full-length cDNA library and microarray data. Genome Res 12:1286-1293.
18. Koishi K, Dalzell KG, McLennan IS. 2000. The expression and structure of TGF-β2 transcripts in rat muscles. Biochim Biophys Acta 1492:311-319.
19. Koli K, Saharinen J, Hyytiainen M, Penttinen C, Keski-Oja J. 2001. Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech 52:354-362.
20. Konrad L, Albrecht M, Renneberg H, Aumuller G. 2000. Transforming growth factor-β2 mediates mesenchymal-epithelial interactions of testicular somatic cells. Endocrinology 141:3679-3686.
21. Konrad L, Keilani MM, Cordes A, Völck-Badouin E, Laible L, Albrecht M, Renneberg H, Aumüller G. 2005. Rat Sertoli cells express epithelial but also mesenchymal genes after immortalization with SV40. Biochem Biophys Acta 1722:6-14.
22. Kulkarni AB, Thyagarajan T, Letterio JJ. 2002. Function of cytokines within the TGF-β superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol Med 2:303-327.
23. Le Magueresse-Battistoni B, Morera AM, Goddard I, Benahmed M. 1995. Expression of mRNAs for transforming growth factor-β receptors in the rat testis. Endocrinology 136:2788-2791.
24. Lui WY, Lee WM, Cheng CY. 2001. Transforming growth factor-β3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11. Endocrinology 142:1865-1877.
25. Lui WY, Lee WM, Cheng CY. 2003a. TGF-betas: Their role in testicular function and Sertoli cell tight junction dynamics. Int J Androl 26:147-160.
26. Lui WY, Lee WM, Cheng CY. 2003b. Transforming growth factor β3 regulates the dynamics of Sertoli cell tight junctions via the p38 mitogen-activated protein kinase pathway. Biol Reprod 68:1597-1612.
27. Lui WY, Wong CH, Mruk DD, Cheng CY. 2003c. TGF-β3 regulates the blood-testis barrier dynamics via the p38 mitogen activated protein (MAP) kinase pathway: An in vivo study. Endocrinology 144:1139-1142.
28. MacConell LA, Leal AM, Vale WW. 2002. The distribution of betaglycan protein and mRNA in rat brain, pituitary, and gonads: Implications for a role for betaglycan in inhibin-mediated reproductive functions. Endocrinology 143:1066-1075.
29. Madisen L, Lioubin MN, Finerty PJ, Jr., Sutter K, Blake J, Frederick J, Purchio AF. 1991. Expression of recombinant TGF-beta 2(442) precursor and detection in BSC-40 cells. Growth Factors 5:317-325.
30. Miyazono K, Maeda S, Imamura T. 2005. BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16:251-263.
31. Mullaney BP, Skinner MK. 1993. Transforming growth factor-beta (β1, β2, and β3) gene expression and action during pubertal development of the seminiferous tubule: Potential role at the onset of spermatogenesis. Mol Endocrinol 7:67-76.
32. Ogasa H, Noma T, Murata H, Kawai S, Nakazawa A. 1996. Cloning of a cDNA encoding the human transforming growth factor-beta type II receptor: Heterogeneity of the mRNA. Gene 181:185-190.
33. Ogawa Y, Schmidt DK, Dasch JR, Chang RJ, Glaser CB. 1992. Purification and characterization of transforming growth factor-β2.3 and -β1.2 heterodimers from bovine bone. J Biol Chem 267:2325-2328.
34. Olaso R, Pairault C, Habert R. 1998. Expression of type I and II receptors for transforming growth factor β in the adult rat testis. Histochem Cell Biol 110:613-618.
35. Roberts KP, Banerjee PP, Tindall JWM, Zirkin BR. 1995. Immortalization and characterization of a Sertoli cell line from the adult rat. Biol Reprod 53:1446-1453.
36. Rotzer D, Roth M, Lutz M, Lindemann D, Sebald W, Knaus P. 2001. Type III TGF-β receptor-independent signalling of TGF-β2 via TβRII-B, an alternatively spliced TGF-β type II receptor. EMBO J 20:480-490.
37. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. 1995. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576.
38. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T. 1997. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 124:2659-2670.
39. Santamaria L, Martin R, Codesal J, Ramirez R, Paniagua R. 1995. Immunohistochemical quantitative study of the peritubular lamina propria after induction of testicular atrophy induced by epinephrine. Int J Androl 18:295-306.
40. Sha X, Yang L, Gentry LE. 1991. Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor beta 1. J Cell Biol 114:827-839.
41. Sorek R, Shamir R, Ast G. 2004. How prevalent is functional alternative splicing in the human genome? Trends Genet 20:68-71.
42. Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler S, Grail D, Small C, Weinberg RA, Sizeland AM, Zhu HJ. 2003. Heart and liver defects and reduced transforming growth factor β2 sensitivity in transforming growth factor β type III receptor-deficient embryos. Mol Cell Biol 23:4371-4385.
43. Suzuki A, Shioda N, Maeda T, Tada M, Ueno N. 1994. Cloning of an isoform of mouse TGF-beta type II receptor gene. FEBS Lett 355:19-22.
44. Teerds KJ, Dorrington JH. 1993. Localization of transforming growth factor β1 and β2 during testicular development in the rat. Biol Reprod 48:40-45.
45. ten Dijke P, Hill CS. 2004. New insights into TGF-β-Smad signalling. Trends Biochem Sci 29:265-273.
46. Tomoda T, Kudoh T, Noma T, Nakazawa A, Muramatsu M, Arai K. 1994. Molecular cloning of a mouse counterpart for human TGF-beta type I receptor. Biochem Biophys Res Commun 198:1054-1062.
47. Vale W, Wiater E, Gray P, Harrison C, Bilezikjian L, Choe S. 2004. Activins and inhibins and their signaling. Ann NY Acad Sci 1038:142-147.
48. Wolkowicz MJ, Coonrod SA, Reddi PP, Millan JL, Hofmann MC, Herr JC. 1996. Refinement of the differentiated phenotype of the spermatogenic cell line GC-2spd(ts). Biol Reprod 55:923-932.
49. Wong CH, Mruk DD, Lui WY, Cheng CY. 2004. Regulation of blood-testis barrier dynamics: An in vivo study. J Cell Sci 117:783-798.
50. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. 2003. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964-968.